Effect of COVID-19 Pandemic on Pediatric Cancer Care

Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma

NCT05019716 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral Therapy

NCT04327583 ·Status: UNKNOWN ·Phase: NA

Pharmacokinetics of Paclitaxel in Correlation With Adverse Events in Cancer Patients With and Without Liver Impairment

NCT04863144 ·Status: UNKNOWN

Screening of Cancer Patients to Assess Impact of COVID-19

NCT04373005 ·Status: TERMINATED

Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients

NCT05670054 ·Status: UNKNOWN ·Phase: PHASE3

Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel

NCT00697437 ·Status: COMPLETED ·Phase: PHASE2

Oral Topotecan to Treat Recurrent or Persistent Solid Tumors

NCT00382733 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Influence of Intermittent Fasting on Locally Advanced Breast Cancer Patients

NCT06174259 ·Status: RECRUITING ·Phase: NA

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

NCT03987555 ·Status: SUSPENDED

Livertoxcicity in Acute Leukemia Patients During Chemotherapy Treatment

NCT06383325 ·Status: NOT_YET_RECRUITING

To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment

NCT04821570 ·Status: UNKNOWN

Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor

NCT04122118 ·Status: COMPLETED ·Phase: NA

Effectiveness of Pharmacist Intervention on Capecitabine Relative Dose Intensity, Adherence, Knowledge & Safety Among Cancer Patients in Malaysia

NCT04175899 ·Status: UNKNOWN ·Phase: NA

A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

NCT04381988 ·Status: TERMINATED ·Phase: PHASE2

Impact of Hospital Pharmacist on Drug Management in Patients With Bronchopulmonary Cancer

NCT06469957 ·Status: COMPLETED

Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors

NCT00113438 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

NCT06297369 ·Status: RECRUITING ·Phase: PHASE2

Impact of Clinical Pharmacy Consultations in Patients With Cancer Treated With Oral Anti-cancer Therapies on the Rate of Serious Adverse Events

NCT02733965 ·Status: UNKNOWN ·Phase: NA

Pharmacogenetics in Non Small Cell Lung Cancer

NCT03791151 ·Status: UNKNOWN

Understanding the Impact of Drug Shortages on Oncology Care Delivery

NCT03953027 ·Status: WITHDRAWN

Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer

NCT04298333 ·Status: COMPLETED ·Phase: PHASE1

Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer

NCT01934335 ·Status: TERMINATED ·Phase: PHASE2

L-Carnitine Protective Effect in Nephrotoxicity

NCT07108777 ·Status: RECRUITING ·Phase: PHASE2

Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year

NCT04455958 ·Status: WITHDRAWN ·Phase: PHASE2

Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy

NCT01998529 ·Status: COMPLETED ·Phase: PHASE1